Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

BACKGROUND: The first meningococcal serogroup C (MenC) conjugate vaccine was licensed in 1999 and introduced in the United Kingdom. Countries that have implemented the MenC vaccine since then in their national immunisation programmes use different schedules. Nevertheless, all involved countries seem...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kaaijk, Patricia, van der Ende, Arie, Berbers, Guy, van den Dobbelsteen, Germie PJM, Rots, Nynke Y
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Debate
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3293716/
https://ncbi.nlm.nih.gov/pubmed/22316426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-35
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki